Gagan Kukreja Shares A Study On Novel Neuroprotective Agents for Ischemic Stroke
Gagan Kukreja, Lead Medicinal Chemistry Strategist at Syngene International Limited, shared on LinkedIn:
”Holding promise as a treatment of Ischemic stroke (IS), an acute cerebrovascular condition, the publication describes a novel class of pyrazole carboxylic acid borneol esters as novel neuroprotective agents demonstrating potent scavenging activity against nitrogen/oxygen free radicals
With preliminary biosafety studies indicating no obvious organ toxicity, the identified candidate B16, not only restored cerebral blood flow and significantly reduces infarct size in middle cerebral artery occlusion/reperfusion (MCAO/R) mice, but also improved sensory and motor functions, and promotes the recovery of neuronal cells and the blood-brain barrier (BBB) in the brain.
Xueyang Jiang et al”
Read the full article here.
Article: Pyrazole carboxylic acid borneol esters: Novel neuroprotective agents with rapid, efficient brain penetration for the treatment of ischemic stroke
Authors: Siyi Li, Yulu Wu, Wang Chen, Peng Zhu, Xin Lu, Jiaming Li, Xiaodong Ma, Xueyang Jiang
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 4, 2026, 17:02Oğuzhan Işılay on Stabilizing Human Blood Clotting Factor VIII
-
Jan 4, 2026, 16:48Sleep Apnea: Full Breakdown from John Chuback
-
Jan 4, 2026, 16:36Edwin Ofori Atta on Permissive Hypertension For Ischemic Stroke
-
Jan 4, 2026, 16:27Nasrin Haghani on The Milli-Spinners: Breakthrough Technology Transforming Stroke Clot Removal
-
Jan 4, 2026, 16:10Godfrey Gandawa on Neuroplasticity in Stroke Rehabilitation
-
Jan 4, 2026, 14:53What Do Blood and Plasma Donors Think About Biobanking? A New Study Reveals Their Attitudes
-
Jan 4, 2026, 14:51First Results from the International BPDCN Registry: Data from 36 Patients Across 12 Countries
-
Jan 4, 2026, 14:51Shreya Agrawal: Top 5 Practical Hematology Lessons from 2025 – Mild Cytopenias are Rarely “Incidental” and More
-
Jan 4, 2026, 14:46We Analyzed Data From the Start of the COVID-19 Pandemic to 2024 – What Did We find?